Newborn Screening for MPS1 and Pompe Disease

/ Print /
| ShareMore
/ Text Size +
8/31/20 10:00 am EST
Virtual Webinar
United States

Newborn Screening for MPS1 & Pompe Disease

This webinar is jointly provided by the Postgraduate Institute for Medicine and Enquiring Minds LLC.

PIM_circle_logo                      EM_logo    

This activity is supported in part by an independent education grant from Sanofi Genzyme.

Join Dr. David Kronn in this free live virtual webinar as he discusses the importance of newborn screening. 

Webinar Overview:

Make real-world decisions and implement expert guidance as you answer diagnostic and therapeutic questions about newborn screening, MPS 1, and Pompe Disease across 3 patient cases. Topics will include:

  • Target patient populations
  • Testing Techniques and recommendations
  • Symptom identification and management
  • Spectrum of disease and determining disease severity
  • Patient-centered and familial considerations

Target Audience

This activity is intended for physicians, genetic counselors, and registered nurses engaged in the care of patients with newborn screening in MPS 1 and Pompe disease.

Date and Time:

This webinar will be held on three separate days

  • Monday, August 17, 2020 10:00 AM – 11:00 AM EDT
  • Monday, August 31, 2020 10:00 AM – 11:00 AM EDT


David Kronn, MD

Associate Professor of Pediatrics, New York Medical College
Director, Inherited Metabolic Disease Center, Westchester Medical Center
Director, Biochemical Genetics Laboratory, Children and Women’s Physicians of Westchester
Chief of Medical Genetics, Inherited Metabolic and Lysosomal Storage Disorders Center, Boston Children’s Health Physicians


  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
  • All other health care professionals completing this course will be issued a statement of participation.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Enquiring Minds, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Genetic Counselors

If you are a Genetic Counselor, you may claim participation in this activity under AMA credit. Your certificate will show that you have participated in this activity and that the activity was awarded for AMA PRA Category 1 Credits™. You may submit this certificate to your governing body for Genetic Counseling continuing education credit.

Continued Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education is 1.0 contact hours.

Faculty Disclosures

David Kronn, MD

  • Receives consulting fees from Sanofi and AskBio
  • Receives fees or non-CME/CE services received directly from a commercial interest or their agents and contracted research from Sanofi

Planners and Managers

The PIM planners and managers have nothing to disclose. The Enquiring Minds planners, managers and medical writers have nothing to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this live activity. To receive CME credit participants must:

Certificates will be emailed to the participant.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.